Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure.
about
Epidemiology and risk profile of heart failurePossible neurocognitive benefits of exercise in persons with heart failureRecommendations for observational studies of comorbidity in multiple sclerosis.Reporting trends of randomised controlled trials in heart failure with preserved ejection fraction: a systematic reviewExercise intolerance in heart failure with preserved ejection fraction: more than a heart problemClinical Phenotypes in Heart Failure With Preserved Ejection FractionDrug therapy for heart failure in older patients-what do they want?Posttraumatic stress and depression: potential pathways to disease burden among heart failure patientsPharmacotherapy for comorbidities in chronic heart failure: a focus on hematinic deficiencies, diabetes mellitus and hyperkalemia.Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiologyDetermining compound comorbidities for heart failure from hospital discharge data.Exploring the value of clinical data standards to predict hospitalization of home care patients.Reporting of patient-centred outcomes in heart failure trials: are patient preferences being ignored?Non-cardiovascular comorbidity, severity and prognosis in non-selected heart failure populations: A systematic review and meta-analysis.Multidrug and optimal heart failure therapy prescribing in older general practice populations: a clinical data linkage study.Casting a Wider Net: Data Driven Discovery of Proxies for Target Diagnoses.International variations in the treatment and co-morbidity of left ventricular systolic dysfunction: data from the EuroHeart Failure Survey.Income level and chronic ambulatory care sensitive conditions in adults: a multicity population-based study in Italy.Comorbidity profiles and inpatient outcomes during hospitalization for heart failure: an analysis of the U.S. Nationwide inpatient sample.Gender differences in and factors related to self-care behaviors: a cross-sectional, correlational study of patients with heart failure.Nontuberculous mycobacteria-associated lung disease in hospitalized persons, United States, 1998-2005.Red blood cell distribution width as a prognostic marker in patients with heart failure and diabetes mellitus.Co-morbidity and potential treatment conflicts in elderly heart failure patients: a retrospective, cross-sectional study of administrative claims data.Rationale and methods of the multicenter randomised trial of a heart failure management programme among geriatric patients (HF-Geriatrics)Validity of heart failure diagnoses in administrative databases: a systematic review and meta-analysisDepression and ambulatory care sensitive hospitalizations among Medicare beneficiaries with chronic physical conditions.A randomized double-blind trial of enalapril in older patients with heart failure and preserved ejection fraction: effects on exercise tolerance and arterial distensibility.The health services burden of heart failure: an analysis using linked population health data-setsTrends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993-2006.Reducing potentially avoidable complications in patients with chronic diseases: the Prometheus Payment approachNoncardiac comorbidities in heart failure with reduced versus preserved ejection fractionSymptoms of anxiety and depression and risk of heart failure: the HUNT StudyMultimorbidity in heart failure: a community perspective.Self-management in heart failure: where have we been and where should we go?Management of chronic heart failure in the older population.Understanding results of trials in heart failure with preserved ejection fraction: remembering forgotten lessons and enduring principlesComorbidity and functional mobility in persons with Parkinson disease.Psychiatric comorbidity and mortality among veterans hospitalized for congestive heart failure.Comorbidity increases the risk of hospitalizations in multiple sclerosis.Primary care practice-based care management for chronically ill patients (PraCMan): study protocol for a cluster randomized controlled trial [ISRCTN56104508].
P2860
Q24630778-500C9DAE-AD35-474D-9F90-2D153D501A36Q26766657-2B5C8748-5390-4C27-BF91-4EF145408072Q26766688-70BA1178-083A-4807-98C4-7A873D266DFBQ26779538-715E257E-AAA3-4311-BD2A-CABD27FACC2AQ26991985-D4F9066D-9C32-4AAB-932C-2DDAB953A044Q28073079-5CCD41F2-5124-488C-849B-61493847757FQ28083086-E7BE97CB-4372-4D0A-92B9-FB9E05AB916EQ28386836-FDCFA2F7-36AD-4782-BABA-722AECFAF45AQ30250020-0C7104D6-25C0-4860-A457-E9F5F9000DF0Q30483582-506F5A14-6488-42AA-B899-7C6D211C098AQ30585464-7A0E7791-E729-47E9-A722-C2CE7508D3ABQ30621186-9C8EF344-72D0-46A3-97DF-857827423C26Q30654172-A73E7593-8C7A-440B-AD7F-F1B59DBCD4B8Q30659393-90E0DF92-D0E0-41A0-854B-875F0EA916B1Q30725233-ED9DDFB2-71E7-428E-A885-14319E60AA0DQ31055217-869ED719-186A-4D02-9513-B8E4D890B5EBQ31064781-9F017866-01DE-40AD-BC49-4FD7F57B65D7Q33517933-22A3C8B7-C0FF-49AB-A41B-BA5F2D083F0DQ33756448-FAD44070-93D4-4B7F-9521-36E638C7DB5EQ33758107-31EA2EE7-3C61-47CE-8C37-4D4F72761824Q33836651-0D39EA37-BBF4-4747-B6D7-CDE14EEE2BE9Q33883706-B9D5376A-152A-4E0E-A5D3-126A600EF990Q33948375-4AFF40A0-9292-4013-AC38-DAB6D3BF1766Q33983931-70216C8F-496A-4576-AFF8-AA469872A1E2Q34050674-AC2655F4-706A-4C27-A008-C2616E2E82AAQ34066886-B6429710-0431-4750-AF7D-2F39C7B6C764Q34152031-61ED2A65-8ED7-4ABF-9561-31D423124B67Q34245597-A749DE68-EF98-4A83-84FF-F45F78E88E6AQ34490213-36DFB82F-4565-4EA9-938A-4131A272AC35Q34534589-034CD461-C820-4B61-A8DF-92937D3FCED8Q34625223-D0CDF180-9B46-4C7F-8AB8-1E4093C98A60Q34631790-7697E274-2586-4D21-8A72-555A567892A9Q34808976-04FC909F-C2BB-4F2B-9AD2-F7822E4F0B70Q34883320-95EC3D54-9135-4EE6-BBAB-643DF3B1662EQ34930544-0471E02E-4AD8-4AEE-9C3A-BE1222788DDEQ34999474-E2678838-3954-4F5C-A130-0F9CF3DBF3DBQ35067656-CE099F19-0828-4970-A007-22F2C58F93B5Q35090340-B18B6C68-355E-41FC-8A55-5EED929F64C7Q35106304-7331AD4A-AD97-40FD-BF71-8A77F235EC3FQ35121767-2B7B726C-AD54-42FA-B4FC-C7FB24E6FDCB
P2860
Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Noncardiac comorbidity increas ...... es with chronic heart failure.
@en
Noncardiac comorbidity increas ...... es with chronic heart failure.
@nl
type
label
Noncardiac comorbidity increas ...... es with chronic heart failure.
@en
Noncardiac comorbidity increas ...... es with chronic heart failure.
@nl
prefLabel
Noncardiac comorbidity increas ...... es with chronic heart failure.
@en
Noncardiac comorbidity increas ...... es with chronic heart failure.
@nl
P2093
P1476
Noncardiac comorbidity increas ...... es with chronic heart failure.
@en
P2093
Albert W Wu
Gary Gerstenblith
Gerard F Anderson
Joel B Braunstein
Marlene Niefeld
Robert Herbert
Wendy Weller
P304
P356
10.1016/S0735-1097(03)00947-1
P407
P577
2003-10-01T00:00:00Z